Facing fearful odds--a conference summary.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004357:Drug Synergism; D005978:Glutathione / Q000502:physiology; D006801:Humans; D006931:Hyperbaric Oxygenation; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009593:Nitroimidazoles / Q000627:therapeutic use; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009593:Nitroimidazoles; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D005978:Glutathione